News AZ suffers setback as NICE slaps restrictions on Fasenra Fasenra can only be used after GSK rival, NICE says in draft decision
News NHS does not value CF patients, says Vertex CEO in letter to... But Vertex dismisses rumours it will quit the UK
News NHS England okays funding for cholesterol-lowering drug Lojuxta will be available to patients this year
News NICE rejects BMS immunotherapy in advanced bladder cancer No review for three years after final guidance
News Fury as NHS rejects cystic fibrosis drug price offer It may be the 70th birthday of the NHS but this was no day of celebration for a group of patients with cystic fibrosis who have been told by officials there is no way forward in a pricing r
News Roche drug too pricey in progressive MS, says NICE Ocrevus is effective but too pricey in PPMS, says NICE
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
